Cargando…
Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease
Inhaled corticosteroids are widely used in the treatment of chronic obstructive pulmonary disease (COPD). However, their use has been questioned for appropriate dose and a possible increased risk of pneumonia. Here, we reviewed patients with COPD who had received fluticasone–salmeterol combination t...
Autores principales: | Yasui, Hideki, Inui, Naoki, Fujisawa, Tomoyuki, Karayama, Masato, Enomoto, Noriyuki, Nakamura, Yutaro, Kuroishi, Shigeki, Ohba, Hisano, Yokomura, Koshi, Sato, Jun, Sato, Masaki, Koshimizu, Naoki, Toyoshima, Mikio, Yamada, Takashi, Masuda, Masafumi, Shirai, Toshihiro, Suda, Takafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987896/ https://www.ncbi.nlm.nih.gov/pubmed/29881320 http://dx.doi.org/10.1177/1179548418771702 |
Ejemplares similares
-
Prognostic Factors for Myositis-Associated Interstitial Lung Disease
por: Fujisawa, Tomoyuki, et al.
Publicado: (2014) -
Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients
por: Kusagaya, Hideki, et al.
Publicado: (2012) -
Evaluation of Fluticasone Propionate and Fluticasone Propionate/Salmeterol Combination on Exercise in Pediatric and Adolescent Patients with Asthma
por: Murray, John J, et al.
Publicado: (2011) -
Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma
por: Houghton, Catherine M, et al.
Publicado: (2007) -
Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis
por: Aono, Yuya, et al.
Publicado: (2020)